In SLE patients, the level of immune activation of CD4+ and whole T cells clearly, of CD8+ T cells slightly correlated with disease activity, determined by SLEDAI (Figure 5C and Table 1). This evidence concerns the gene CD8A and systemic lupus erythematosus.